Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Interim Management Statement

6 Nov 2013 09:10

RNS Number : 3286S
Mandarin Oriental International Ltd
06 November 2013
 



To: Business Editor For immediate release

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

6th November 2013 - Mandarin Oriental International Limited has today issued its Interim Management Statement covering the period from 1st July to 5th November 2013.

 

The trading momentum continued to be positive for the Group during the period. Results from its Asian hotels remained steady, while in Europe earnings benefited from further stabilization of the Paris hotel. In The Americas, increased demand led to improved performance across the portfolio.

 

During the period, the Group announced two new management contracts. A 231-room hotel in the central business district of Chongqing is due to open in 2016, followed in 2017 by the opening of a 190-room hotel in Shenzhen. These projects will bring the total number of hotels under operation or development in mainland China to seven. In August, the Group ceased management of the Chiang Mai hotel, and the previously announced project in St. Kitts will no longer proceed. Within the next 18 months, four new hotels are scheduled to open, in Taipei, Bodrum, Marrakech and Beijing.

 

Mandarin Oriental's balance sheet remains strong, with net debt at 31st October 2013 largely unchanged from that reported at the half year.

 

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the most luxurious hotels, resorts and residences. The Group has grown from a well-respected Asian hotel company into a global brand and now operates, or has under development, 45 hotels representing over 11,000 rooms in 26 countries, with 20 hotels in Asia, 11 in The Americas and 14 in Europe, Middle East and North Africa. In addition, the Group operates or has under development, 13 Residences at Mandarin Oriental connected to its properties. Mandarin Oriental International Limited is incorporated in Bermuda and has a premium listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

Hamish Ross (852) 2895 9288

Sally de Souza (852) 2895 9167

 

GolinHarris

Kennes Young (852) 2501 7987

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKQLBBXFFBFBV
Date   Source Headline
23rd Jan 201910:38 amRNSShares Purchase
22nd Jan 201910:48 amRNSShares Purchase
21st Jan 201911:21 amRNSShares Purchase
20th Dec 201811:34 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:12 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
12th Oct 201812:00 pmRNSShares Purchase
10th Oct 201810:45 amRNSShares Purchase
10th Oct 201810:12 amRNSDirector/PDMR Shareholding
9th Oct 201811:03 amRNSShares Purchase
5th Oct 201810:47 amRNSShares Purchase
5th Oct 201810:36 amRNSAdditional Listing
4th Oct 201811:30 amRNSShares Purchase
3rd Oct 201811:14 amRNSShares Purchase
2nd Oct 201811:36 amRNSShares Purchase
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
26th Sep 201810:10 amRNSDividend
21st Sep 201811:33 amRNSDividend
29th Aug 201810:08 amRNSCirc re. Scrip Dividend Scheme
17th Aug 201810:26 amRNSDF Partnership With Robinsons Receive PCC Approval
27th Jul 201810:47 amRNSHalf-year Report
27th Jul 201810:41 amRNSHalf-year Report
26th Jul 201811:07 amRNSPT Astra International Tbk Half Year Report
26th Jul 201810:06 amRNSHalf-year Report
26th Jul 201810:06 amRNSHalf-year Report
26th Jul 201810:06 amRNSHalf-year Report
25th Jul 201810:35 amRNSFirst Half of 2018 Results of PT Hero
28th Jun 201810:11 amRNSNotice of 2018 Half-Yearly Results
7th Jun 20187:00 amRNSMandarin Oriental International Ltd Announcement
31st May 201810:25 amRNSTotal Voting Rights
16th May 201810:14 amRNSDirector/PDMR Shareholding
11th May 201810:10 amRNSAdditional Listing
10th May 20185:06 pmRNSDirectorate Change
10th May 20185:05 pmRNSResult of AGM
10th May 20185:05 pmRNSNon-Routine Resolutions submitted via NSM
10th May 201812:34 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.